Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
233.2 USD | +0.40% | -3.10% | -4.38% |
Apr. 05 | Becton Dickinson Releases New Image-Enabled Cell Sorters | MT |
Apr. 05 | Becton, Dickinson and Company Increases Access to Cutting-Edge Image-Enabled, Spectral Cell Sorters | CI |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- For the past twelve months, EPS forecast has been revised upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The group shows a rather high level of debt in proportion to its EBITDA.
- With an expected P/E ratio at 34.52 and 28.01 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- With an enterprise value anticipated at 3.93 times the sales for the current fiscal year, the company turns out to be overvalued.
- The company is not the most generous with respect to shareholders' compensation.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-4.38% | 67.09B | A | ||
-4.36% | 184B | C+ | ||
-3.87% | 105B | C | ||
+8.23% | 51.61B | B- | ||
+15.54% | 47.55B | B- | ||
+0.60% | 39.95B | B+ | ||
+7.16% | 27.62B | A- | ||
-12.48% | 25.74B | B | ||
-1.68% | 25.62B | B | ||
+11.40% | 24.93B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- BDX Stock
- Ratings Becton, Dickinson and Company